Response Evaluation and Survival Prediction Following PD‐1 Inhibitor in Patients With Advanced Hepatocellular Carcinoma: Comparison of the RECIST 1.1, iRECIST, and mRECIST Criteria

BACKGROUND: Precise evaluation of the efficacy of immunotherapy is critical in the effective management and treatment of advanced hepatocellular carcinoma (HCC). Therefore, the purpose of this study was to compare the response assessments achieved by different criteria and to evaluate the correlatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Meng, Zhang, Chunhui, Nie, Jianhua, Sun, Yajuan, Xu, Ye, Wu, Fangfang, Huang, Yuhong, Li, Shun, Wang, Yuan, Zhou, Yang, Zheng, Tongsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697350/
https://www.ncbi.nlm.nih.gov/pubmed/34956885
http://dx.doi.org/10.3389/fonc.2021.764189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697350/
https://www.ncbi.nlm.nih.gov/pubmed/34956885
http://dx.doi.org/10.3389/fonc.2021.764189

Ejemplares similares